Fulcrum Therapeutics Announces $80 Million Series B Financing
MassChallenge Awards $1.7M in Cash Prizes to Top Startups in Boston and Rhode Island
Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
Biotech ALS-focused QurAlis raises $5.5M in seed money, wins Pfizer ticket to LabCentral
QurAlis Raises $5.5 Million Seed Round - Wins Pfizer Sponsored Golden Ticket to LabCentral
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
Astellas Pharma : buys Potenza Therapeutics for up to $405m
Top 10 ALS Stories of 2018
The 2019 30-under-30 getting personal to fix the system
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
